Longeveron (LGVN) Net Equity Issued and Repurchased (2020 - 2025)

Longeveron's (LGVN) quarterly Net Equity Issued and Repurchased came in at $15.9 million in Q4 2025, up 95.24% quarter-over-quarter from $8.1 million in Q3 2024.

Longeveron (LGVN) Net Equity Issued and Repurchased (2020 - 2025) Analysis & Trends

Longeveron's Net Equity Issued and Repurchased history runs 4 years deep, the most recent figure standing at $15.9 million for Q4 2025.

  • On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $15.9 million in Q4 2025; TTM through Dec 2025 was $28.7 million, a 122.8% increase from a year earlier, with the FY2025 full-year figure at $5.0 million, down 61.29% from the prior year.
  • Net Equity Issued and Repurchased climbed to $15.9 million in Q4 2025 per LGVN's latest filing, from $8.1 million in the prior quarter.
  • Across five years, Net Equity Issued and Repurchased topped out at $26.7 million in Q1 2021 and bottomed at -$1000.0 in Q4 2021.
  • The 3-year median for Net Equity Issued and Repurchased is $6.4 million (2024), against an average of $9.2 million.
  • Biggest YoY gain for Net Equity Issued and Repurchased was 2326.91% in 2021; the steepest drop was 2326.91% in 2021.
  • Year by year, Net Equity Issued and Repurchased stood at -$1000.0 in 2021, then surged by 814500.0% to $8.1 million in 2024, then soared by 95.24% to $15.9 million in 2025.
  • Per Business Quant, the three latest LGVN Net Equity Issued and Repurchased figures stand at $15.9 million (Q4 2025), $8.1 million (Q3 2024), and $4.6 million (Q2 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 163.10 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 141.90 Mn
10 Longeveron 3.97 Mn -11.79 Mn 264,000.00 -

Historic Data

Download Data
DateValue
Dec 31, 2025 15.90 Mn
Dec 31, 2025 15.90 Mn
Sep 30, 2024 8.14 Mn
Sep 30, 2024 8.14 Mn
Jun 30, 2024 4.62 Mn
Jun 30, 2024 4.62 Mn
Mar 31, 2024 100,000.00
Mar 31, 2024 100,000.00
Dec 31, 2021 -1,000.00
Dec 31, 2021 -1,000.00
Mar 31, 2021 26.70 Mn
Mar 31, 2021 26.70 Mn
Mar 31, 2020 1.10 Mn
Mar 31, 2020 1.10 Mn